Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass

Aging

Volumn 3, Issue 12, 2011, Pages 1169-1177

  Maejima, Yuko ^a   Iwasaki, Yusaku ^a   Yamahara, Yui ^a   Kodaira, Misato ^a   Sedbazar, Udval ^a   Yada, Toshihiko ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Energy expenditure; Fatty liver; Feeding; Impaired glucose tolerance; Metabolic syndrome; Oxytocin; Visceral obesity

Indexed keywords

EID: 84859511147     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100408     Document Type: Article

References (26)

1. Kiss A, and Mikkelsen JD. Oxytocin-anatomy and functional assignments: a minireview. Endocr. Regul. 2005; 39:97-105.
2. Donaldson ZR, and Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science. 2008; 322:900-904.
3. Neumann, ID. Brain oxytocin: A key regulator of emotional and social behaviors in both females and males. J. Neuroendocrinol. 2008; 20:858-865.
4. Tomizawa K, Iga N, Lu YF, Moriwaki A, Matsushita M, Li ST, Miyamoto O, Itano T, Matsui H. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nature Neurosci. 2003; 6:384-390.
5. Tung, YC, Ma M, Piper S, Coll A, O'Rahilly S, and Yeo GSH. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J. Neurosci. 2008; 19:12419-12426.
6. Arletti, R., Benelli, A., and Bertolini, A. (1989). Influence of oxytocin on feeding behavior in the rat. Peptides 10, 89-93.
7. Zhang G, Cai D. Circadian intervention of obesity development via resting stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab. 2011; 301:E1004-E1012.
8. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009; 10:355-365.
9. Morton GJ, Thacher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Schwartz MW, Blevins J. Peripheral oxytocin suppresses food intake and causes weight loss in dietinduced obese rats. Am J Phyiol Endocrinol Metab. 2011 (in press).
10. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity. 2009; 17:980-984.
11. Takayanagi Y, Kasahara, Y, Onaka, T, Takahashi N, Kawada T, and Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport. 2008; 19:951-955.
12. Mens WB, Witter A, Van Wismersma Graidanus TB. Penetration of neurophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res. 1983; 262:143-149.
13. Ostrowski N. Oxytocin receptor mRNA expression in rat brain: implications for behavioral integration and reproductive success. Psychoneuroendocrinol.1998; 23:989-1003.
14. Schwartz GJ. Integrative capacity of the caudal brainstem in the control of food intake. Phil Trans R Soc B. 2006; 361:1275-1280.
15. South EH, Ritter RC. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides. 1988; 9:601-612.
16. Mönnikes H, Lauer G, Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res. 1997; 770:277-288.
17. Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F. Mechanisms of the antiobesity effects of oxytocin in diet-induced obese rats. Plos One. 2011; 6:e25565.
18. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001; 81:629-683.
19. Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010; 2010:pii:289645.
20. Ariño J, Bosch F, Gómez-Foix AM, Guinovart JJ. Oxytocin inactivates and phosphorylates rat hepatocyte glycogen synthase. Biochem J. 1989; 261:827-830.
21. Vanpatten S, Karkanias GB, Rossetti L, Cohen DE. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J. 2004; 379:229-233.
22. Björkstrand E, Eriksson M, Uvnäs-Moberg K. Evidence of a peripheral and a central effect of oxytocin on pancreatic hormone release in rats. Neuroendocrinol. 1996; 63:377-383.
23. Gao ZY, Drews G, Henquin JC. Mechanism of the stimulation of insulin release by oxytocin in normal mouse islets. Biochem J. 1991; 276:169-174.
24. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: Implication for cardiovascular regulation. J Chem Neuroanat. 2009; 38:197-208.
25. Toriya M, Maekawa F, Maejima Y, Onaka T, Fujiwara K, Nakagawa T, Nakata M, Yada T. Long-term infusion of Brain-Derived Neurotrophic Factor reduces food intake nad body weight via corticotrophin-releasing hormone pathway in the paraventricular nucleus of hypothalamus. J Neuroendocrinol. 2010; 22:987-995.
26. Kohno D, Nakata, Maejima Y, Shimizu H, Sedbazar U, Yoshida, N, Dezaki K, Onaka T, Mori M, and Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinol. 2008; 149:1295-1301.